IP Library › Assignment 048438/0275
Patent Assignment
Reel/Frame 048438/0275

Merger and Change of Name

Recorded: 2019-02-26 Pages: 16
Assignors
Assignee
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVENUE, BRONX, NEW YORK, 10461
Covered Properties (379)
Methods and Compositions to Inhibit Metastasis and to Treat Fibrosis and to Enhance Wound Healing
Modified Paramagnetic Nanoparticles for Targeted Delivery of Therapeutics and Methods Thereof
Epigenetic Stem Cell Commitment-Associated Signature
Cellular Platform for Rapid and Comprehensive T-Cell Immunomonitoring
Treatment of H. Pylori Infections Using Mtan Inhibitors
Methods of Grading Carcinomas
Methods and Assays for Treating Hantavirus Infections
Recombinant Herpes Simplex Virus 2 (Hsv-2) Vaccine Vectors
Treatment of Multiple Sclerosis by Inhibition of Allograft Inflammatory Factor-1
Targeting Dimerization of Bax to Modulate Bax Activity
Use of Tgf-Beta Antagonists Ot Treat Type-2 Diabetes
Therapy for Filovirus Infection
Programmed Cargo Release Using Nucleic Acid-Stabilized Micelles
Method for Producing Radiobacteria for Therapy of Cancer
Multi-Specific Antibodies for Cross-Neutralization of Multiple Filovirus Glycoproteins
Methods to Accelerate Antibody Diversification
BTNL9 and Ermap as Novel Inhibitors of the Immune System for Immunotherapies
Peptides for Blocking IL1RAP Protein-Protein Interaction and Uses Thereof for Treatment of Disease
Treatment of Cancer Using Recall Antigens Delivered by Attenuated Bacteria
Antibody Therapeutics Against Filovirus Infections and Uses Thereof
Fgf Receptor Ligands for Treating Diabetes and Obesity
Tmem Active Test and Uses Thereof in Diagnosis, Prognosis and Treatment of Tumors
Mtap Inhibitors for the Treatment of Sickle Cemtap Disease
Reversal of Persistent Ros Generation After Transient Hyperglycemia
Synthetic Antibodies to Bax and Uses Thereof
Microbial Hyperswarmers and Uses Thereof
An Optogenetic System Based on Bacterial Phytochrome Controllable with Near Infra-Red Light
Therapeutic Tnfr-1B Targets and Uses Thereof
Use of 13C Derivatization Reagents for Gas or Liquid Chromatography-Mass Spectroscopy Chemical Identification and Quantification
Method of Ameliorating Side Effects of Sickle Cell Disease Treatments
Nuclear Receptor Set Domain Containing Protein 2 Transition State and Uses Thereof
Residue-Based Pharmacophore Method for Identifying Cognate Protein Ligands
Cemoenzymatic Synthesis of S-Nucleosyl Amino Acids (Sna), Analogs of S-Adenosyl-L-Methionine and S-Adenosyl-L-Homocysteine and Uses Thereof
Dengue Virus Glycoprotein E Diii Variants and Uses Thereof
PAK1 Inhibitors and Uses Thereof
Engineered Pd-1 Variants
Variant Pd-L1 Polypeptides, T-Cell Modulatory Multimeric Polypeptides, and Methods of Use Thereof
Methods for Treating Cancer by Targeting VCAM1 and Maea
Pu.1 Inhibitors
Stem Cell-Produced Microvesicles for Treating Tendon Pathologies
Chemically Modified Rna Aptamers and Uses Thereof
Drug Targeting of Human Indoleamine 2,3-Dioxygenase
Pxr Agonists and Uses Thereof for Gut Barrier Dysfunction Treatment and Prevention
Co-Localization at Molecular Resolution of Multiple Fluorescence Channels Acquired Using Optical Microscopy
Sol-Gel/Hydrogel Therapeutic Delivery System and Methods Thereof
Characterization of S-Adenosyl-L-Methionine-Consuming Enzymes with 1-Step Ez-Mtase: a Universal Coupled-Assay
Small Molecule Bax Inhibitors and Uses Thereof
Precision Activation of Hiv-Specific Ctls to Eliminate Reactived Latent T Cells
Non-Invasive Optogenetic Stimulation Method to Regulate Glucose Metabolism in the Liver and Brown Adipose Tissue
Rna Tagging System for Visualization of Single Mrna Molecules
Bax Activators and Uses Thereof in Cancer Therapy
Method for Treating Neoadjuvant Chemotherapy-Induced Metastasis
Methods for Expanding Hematopoietic Stem Cells Using Revitalized Mesenchymal Stem Cells
High Resolution Intravital Imaging and Uses Thereof
Broad Spectrum Viral Inhibitor
Inhibitors of Purine Import in Parasites and Uses Thereof
Mitofusin Activators and Uses Thereof
Prevention and Treatment of Viral Infections
Combined Markers for Metastatic Cancer and Uses Thereof
Method and Compounds for Inhibiting Lipid Biosynthesis of Bacteria and Plants
Patent: 5,702,935 →
Application: 08/234,011 →
L5 Shuttle Phasmids
Patent: 5,750,384 →
Application: 08/247,901 →
Treatment of Newborn Jaundice
Patent: 5,589,504 →
Application: 08/279,899 →
Hybridoma-Producing Nso Myeloma Cell Line
Patent: 5,565,337 →
Application: 08/294,416 →
Methods of Treatment of Viral Disease with Inhibitors of Sphingolipid Biosynthesis
Application: 08/332,969 →
Monocyte Adhesion Protein and Monoclonal Antibody Thereto
Patent: 5,541,296 →
Application: 08/357,535 →
Antimycobacterial Compounds and Method of Using Same
Patent: 5,648,392 →
Application: 08/386,917 →
Identification of Mycobacterium Tuberculosis Complex Species
Patent: 5,656,424 →
Application: 08/388,916 →
Method for Proliferating VY2V&2 T Cells
Patent: 5,639,653 →
Application: 08/390,881 →
Novel Hemoglobin Crosslinkers
Patent: 5,585,484 →
Application: 08/425,137 →
Nucleic Acid Encoding Rhodococcus Phenylalanine Dehydrogenase
Patent: 5,851,810 →
Application: 08/461,990 →
Recombinant Mycobacteria
Patent: 5,854,055 →
Application: 08/463,942 →
Peptides Which Bind to Anti-Double Stranded Dna Antibody
Patent: 6,001,964 →
Application: 08/531,832 →
Method of Simultaneously Enhancing Analgesic Potency and Attenuating Dependence Liability Caused by Morphine and Other Bimodally-Acting Opioid Agonists
Patent: 5,580,876 →
Application: 08/552,296 →
Thyroid Sodium/Iodide Symporter and Nucleic Acid Encoding Same
Patent: 6,391,579 →
Application: 08/595,553 →
Rep-Max Protein Having Anti-Oncogenic Activity and Uses Thereof
Patent: 5,811,298 →
Application: 08/609,046 →
D29 Shuttle Phasmids and Uses Thereof
Patent: 5,773,267 →
Application: 08/614,770 →
Transgenic Organisms with Altered Telomerase Activity
Application: 08/623,166 →
Transgenic Mice Having Modified Cell-Cycle Regulation
Patent: 5,919,997 →
Application: 08/627,610 →
Polycystic Kidney Disease PKD2 Gene and Uses Thereof
Patent: 6,031,088 →
Application: 08/651,999 →
Method and Compounds for Inhibiting Lipid Biosynthesis of Bacteria and Plants
Patent: 5,837,480 →
Application: 08/700,306 →
Mycobacterial Species-Specific Reporter Mycobacteriophages
Patent: 6,300,061 →
Application: 08/705,557 →
Human Prostaglandin Transporter
Patent: 5,792,851 →
Application: 08/706,936 →
Novel Hemoglobin Crosslinkers
Patent: 5,750,725 →
Application: 08/720,250 →
Pancreatic Beta Cells for Allogeneic Transplantation Without Immunosuppression
Patent: 6,156,306 →
Application: 08/732,155 →
Method for Detecting Hemolysis
Patent: 6,989,240 →
Application: 08/746,635 →
Publication: US 2002/0012952
Recombinant Mycobacteria Auxotrophic for Diaminopimelate
Patent: 6,221,364 →
Application: 08/747,177 →
Antimycobacterial Compounds and Method of Using Same
Patent: 5,837,732 →
Application: 08/766,273 →
Method of Simultaneously Enhancing Analgesic Potency and Attenuating Dependence Liability Caused by Exogenous and Endogenous Opioid Agonists
Patent: 36,547 →
Application: 08/782,452 →
Gene Therapy for Alleviating Erectile Dysfunction
Patent: 6,150,338 →
Application: 08/799,144 →
Vector Constructs for the Selection and Identification of Open Reading Frames
Patent: 5,981,182 →
Application: 08/816,721 →
Embcab Operon of Mycobacteria and Mutants Thereof
Patent: 6,015,890 →
Application: 08/822,586 →
TM4 Conditional Shuttle Phasmids and Uses Thereof
Patent: 5,972,700 →
Application: 08/938,059 →
Myc Homology Region Ii- Associated Protein
Patent: 6,040,425 →
Application: 08/946,692 →
Inhibitors of Nucleoside Metabolism
Patent: 5,985,848 →
Application: 08/949,388 →
A Method for Detecting Arthropods
Patent: 5,997,846 →
Application: 08/971,384 →
Mycobacteriophages and Uses Thereof
Patent: 5,968,733 →
Application: 09/014,560 →
Transition-State Inhibitors for Nucleoside Hydrolase and Transferase Reactions
Patent: 6,121,296 →
Application: 09/017,097 →
Novel Hemoglobin Crosslinkers
Patent: 6,017,943 →
Application: 09/018,284 →
L5 Shuttle Phasmids
Patent: 5,994,137 →
Application: 09/075,904 →
Inhibitors of Nucleoside Metabolism
Patent: 6,066,722 →
Application: 09/172,321 →
Visualization of Rna in Living Cells
Patent: 6,203,986 →
Application: 09/177,268 →
Inib,Inia and Inic Genes of Mycobacteria and Methods of Use
Patent: 6,268,201 →
Application: 09/177,349 →
One Step Allelic Exchange in Mycobacteria Using in Vitro Generated Conditional Transducing Phages
Patent: 6,271,034 →
Application: 09/350,048 →
Dim Mutants of Mycobacteria and Use Thereof
Patent: 6,290,966 →
Application: 09/350,326 →
Polycystic Kidney Disease PKD2 Gene and Uses Thereof
Patent: 6,228,591 →
Application: 09/385,752 →
Mycobacterial Species-Specific Reporter Mycobacteriophages
Patent: 6,225,066 →
Application: 09/426,436 →
Inhibitors of nucleoside metabolism
Patent: 6,228,847 →
Application: 09/496,741 →
Gene therapy for regulating bladder smooth muscle tone
Patent: 6,239,117 →
Application: 09/531,968 →
A Method of Enhancing Relaxation of Penile Smooth Muscle by Introduction of Dna Encoding Maxi-K Potassium Channel Protein
Patent: 7,030,096 →
Application: 09/531,969 →
Gene therappy for regulating penile smooth muscle tone
Patent: 6,271,211 →
Application: 09/532,138 →
Peptide Compositions for the Treatment of Hiv Infection
Patent: 6,447,778 →
Application: 09/599,286 →
Inhibitors of Nucleoside Metabolism
Patent: 6,492,347 →
Application: 09/820,276 →
Publication: US 2002/0061898
Process for Preparing 2-Pyrrolidinyl-1H-Pyrrolo[3,2-D]Pyrimidine Inhibitors of Nucleoside Metabolism
Patent: 6,693,193 →
Application: 09/958,219 →
Thyroid Sodium/Iodide Symporter and Nucleic Acid Encoding Same
Patent: 6,803,199 →
Application: 09/995,007 →
Publication: US 2002/0123102
Size Enhanced Hemoglobins: Surface Decoration and Crosslinking of the Protein with Polyoxy Alkylene Glycols
Patent: 7,019,117 →
Application: 10/198,732 →
Publication: US 2004/0002443
Inhibitors of Nucleoside Metabolism
Patent: 6,803,455 →
Application: 10/268,652 →
Publication: US 2003/0096830
SIR2 Products and Activities
Patent: 6,987,091 →
Application: 10/301,514 →
Publication: US 2003/0149261
Memory Assessment by Retrieval Speed and Uses Thereof
Patent: 7,314,444 →
Application: 10/350,155 →
Publication: US 2003/0181793
Attenuated Mycobacterium Tuberculosis Vaccines
Patent: 7,722,861 →
Application: 10/351,452 →
Publication: US 2004/0001866
5H-Pyrrolo[3,2-D] Pyrimidine Inhibitors of Nucleoside Phosphorylases and Nucleosidases
Patent: 7,553,839 →
Application: 10/524,995 →
Publication: US 2006/0160765
Modified Hemoglobin and Methods of Making Same
Patent: 7,501,499 →
Application: 10/538,976 →
Publication: US 2006/0135753
Use of Mycrobacterial Vaccines in CD4+ or CD8+ Lymphocyte-Deficient Mammals
Patent: 8,084,041 →
Application: 10/542,958 →
Publication: US 2007/0202131
Globin variant gene methods and compositions
Application: 10/547,980 →
Publication: US 2007/0066548
Antigens Targeted by Prevalent Pathogenic T Cells in Type 1 Diabetes and Uses Thereof
Patent: 8,758,767 →
Application: 10/557,273 →
Publication: US 2008/0153112
SIR2 Regulation
Patent: 8,383,653 →
Application: 10/560,676 →
Publication: US 2011/0178102
Methods and Compositions for Inhibition of BCL6 Repression
Patent: 7,919,578 →
Application: 10/582,662 →
Publication: US 2009/0018083
Inhibition of Hiv-1 Virion Production by a Transdominant Mutant of Integrase Interactor 1(INI1)/HSNF5
Patent: 7,326,416 →
Application: 10/624,080 →
Publication: US 2004/0091487
Methods of Applying Ionization Radiation for Therapy of Infections
Patent: 7,651,689 →
Application: 10/704,469 →
Publication: US 2004/0115203
Process for Preparing Inhibitors of Nucleoside Metabolism
Patent: 7,022,852 →
Application: 10/737,724 →
Publication: US 2004/0181063
Radiolabeled Antibodies for Treatment of Tumors
Patent: 7,402,385 →
Application: 10/775,869 →
Publication: US 2004/0156780
Inhibitors of Nucleoside Metabolism
Patent: 7,211,653 →
Application: 10/932,841 →
Publication: US 2005/0026936
Thyroid Sodium/Iodide Symporter and Nucleic Acid Encoding Same
Patent: 7,320,863 →
Application: 10/937,239 →
Publication: US 2005/0125846
Polycystic Kidney Disease PKD2 Gene and Uses Thereof
Patent: 7,294,465 →
Application: 11/040,384 →
Publication: US 2005/0170399
Use of alkylureas for treating acne
Application: 11/049,377 →
Publication: US 2005/0272819
Attenuated Mycobacterium Tuberculosis Vaccines
Patent: 7,758,874 →
Application: 11/109,056 →
Publication: US 2005/0260232
Ceramide Derivatives as Modulators of Immunity and Autoimmunity
Patent: 7,772,380 →
Application: 11/211,653 →
Publication: US 2006/0052316
Biological Markers for Longevity and Diseases and Uses Thereof
Patent: 7,491,543 →
Application: 11/229,327 →
Publication: US 2006/0068432
SIR2 Products and Activities
Patent: 7,432,246 →
Application: 11/248,523 →
Publication: US 2006/0058520
Process for Preparing Inhibitors of Nucleoside Metabolism
Patent: 7,211,677 →
Application: 11/297,954 →
Publication: US 2006/0089498
Method for Preparing 3-Hydroxy-4-Hydroxymethyl-Pyrrolidine Compounds
Patent: 8,183,019 →
Application: 11/628,427 →
Publication: US 2008/0280334
Antigens Targeted by Pathogenic AL4 T Cells in Type 1 Diabetes and Uses Thereof
Patent: 8,318,670 →
Application: 11/658,457 →
Publication: US 2010/0009923
Isolation, Gene Expression, and Chemotherapeutic Resistance of Motile Cancer Cells
Patent: 8,298,756 →
Application: 11/659,514 →
Publication: US 2008/0138805
Process for Preparing Inhibitors of Nucleoside Metabolism
Patent: 7,405,297 →
Application: 11/716,100 →
Publication: US 2007/0161667
Inhibitors of Nucleoside Metabolism
Patent: 7,390,890 →
Application: 11/728,730 →
Publication: US 2007/0197561
Melanin Nanoshells for Protection Against Radiation and Electronic Pulses
Patent: 8,586,090 →
Application: 11/732,130 →
Publication: US 2007/0237829
Ceramide Derivatives as Modulators of Immunity and Autoimmunity
Patent: 8,022,043 →
Application: 11/785,988 →
Publication: US 2007/0238673
Mycobacteria Expressing Hiv-1 and Malaria Antigens
Patent: 7,998,471 →
Application: 11/794,373 →
Publication: US 2008/0254061
Mycobacterial Mutants Affecting Host Apoptosis
Patent: 8,394,388 →
Application: 11/794,506 →
Publication: US 2010/0297185
Nucleic Acid-Like Proteins
Patent: 8,999,894 →
Application: 11/918,109 →
Publication: US 2009/0131266
Inhibition of Membrane Fusion Proteins
Patent: 8,003,332 →
Application: 11/918,835 →
Publication: US 2009/0280473
Pegylated albumin and uses thereof
Patent: 8,741,832 →
Application: 11/921,064 →
Publication: US 2009/0298746
Uses of Pegylated Albumin
Patent: 8,071,546 →
Application: 11/921,689 →
Publication: US 2010/0222260
Measurement of Soluble Tweak Levels for Evaluation of Lupus Patients
Patent: 8,048,635 →
Application: 11/953,360 →
Publication: US 2008/0292622
Transition state sturcture of 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases
Patent: 8,541,567 →
Application: 11/988,651 →
Publication: US 2011/0086812
Assays for S100 Inhibitors
Patent: 8,236,791 →
Application: 11/989,901 →
Publication: US 2010/0216776
Mycobacterial SECA2 Mutants
Patent: 8,101,191 →
Application: 12/087,628 →
Publication: US 2009/0110696
Restoration of Nucleic Acid from Degraded or Formalin-Fixed and Paraffin-Embedded Tissue and Uses Thereof
Patent: 8,497,067 →
Application: 12/087,951 →
Publication: US 2012/0009570
INTRACELLULAR DOMAIN OF A MAMMALIAN Fat1 (Fat1IC)
Patent: 8,586,534 →
Application: 12/150,176 →
Publication: US 2009/0117169
Analogues of Coformycin and Their Use for Treating Protozoan Parasite Infections
Patent: 8,394,950 →
Application: 12/223,746 →
Publication: US 2009/0227532
Methods of Treating Cancer Using Inhibitors of 5'-Methylthioadenosine Phosphorylase
Patent: 8,916,571 →
Application: 12/224,073 →
Publication: US 2010/0222370
Radiosynthesis as an Alternative Energy Utilization Process in Melanized Organisms and Uses Thereof
Patent: 8,652,827 →
Application: 12/225,990 →
Publication: US 2009/0328258
Inhibition of SKP2-Cyclin a Interaction
Patent: 8,173,604 →
Application: 12/226,935 →
Publication: US 2010/0075892
Prostaglandin Transporter Inhibitors
Patent: 8,227,466 →
Application: 12/227,267 →
Publication: US 2009/0233933
Compositions for Sustained Release of Nitric Oxide, Methods of Preparing Same and Uses Thereof
Patent: 8,333,997 →
Application: 12/227,657 →
Publication: US 2009/0297634
Acyclic Amine Inhibitors of 5-Methytioadenosine Phosphorylase and Nucleosidase
Patent: 8,383,636 →
Application: 12/310,597 →
Publication: US 2011/0046167
Acyclic Amine Inhibitors of Nucleoside Phosphorylases and Hydrolases
Patent: 8,853,224 →
Application: 12/310,708 →
Publication: US 2011/0130412
Small Molecule Inhibitors of BCL6
Patent: 8,338,464 →
Application: 12/312,800 →
Publication: US 2010/0130564
Biological markers for longevity and diseases and uses thereof
Patent: 8,399,258 →
Application: 12/315,845 →
Publication: US 2009/0155915
Detection of the Nucleolar Channel System of Human Endometrium and Uses Thereof
Patent: 7,846,680 →
Application: 12/321,603 →
Publication: US 2009/0215074
Azetidine Analogues of Nucleosidase and Phosphorylase Inhibitors
Patent: 8,283,345 →
Application: 12/448,397 →
Publication: US 2010/0168141
Second Generation Low Oxygen Affinity Pegylated Hemoglobins as Oxygen-Carrying Plasma Expanders
Patent: 8,697,645 →
Application: 12/449,832 →
Publication: US 2010/0216695
Mycobacterial Mutants Inducing Il-12
Patent: 8,591,918 →
Application: 12/450,193 →
Publication: US 2012/0141533
Methods for Determining Cytosine Methylation in Dna and Uses Thereof
Patent: 8,642,294 →
Application: 12/451,431 →
Publication: US 2010/0267021
Treatment of Type 2 Diabetes, Metabolic Syndrome, Myocardial Injury and Neurodegeneration with Humanin and Analogs Thereof
Patent: 8,309,525 →
Application: 12/451,524 →
Publication: US 2010/0204099
Fused Pyrimidines as Inhibitors of Nucleoside Phosphorylases and Nucleosidases
Patent: 8,173,662 →
Application: 12/455,537 →
Publication: US 2009/0239885
Metastasis Specific Splice Variants of Mena and Uses Thereof in Diagnosis, Prognosis and Treatment of Tumors
Patent: 8,603,738 →
Application: 12/462,324 →
Publication: US 2010/0047240
Treatment of Autism Spectrum Disorders with Agents That Activate the Locus Coeruleus - Noradrenergic System
Patent: 8,470,546 →
Application: 12/589,854 →
Publication: US 2010/0130566
Bacterial Vaccines with Cell Wall-Associated Ceramide-Like Glycolipids and Uses Thereof
Patent: 9,139,809 →
Application: 12/684,685 →
Publication: US 2010/0183549
Use of Gamma Secretase Inhibitors and Notch Pathway Inhibitors for Treatment and Prevention of Renal Desease
Patent: 8,377,886 →
Application: 12/733,339 →
Publication: US 2010/0222283
Ketoconazole-Derivative Antagonist of Human Pregnane X Receptor and Uses Thereof
Patent: 8,669,260 →
Application: 12/735,368 →
Publication: US 2011/0105522
Fenretinide Derivatives and Uses Thereof as Therapeutic, Diagnostic and Imaging Agents
Patent: 8,460,635 →
Application: 12/735,544 →
Publication: US 2011/0091383
Methods and Compositions for Inhibition of BCL6 Repression
Patent: 8,791,075 →
Application: 12/737,122 →
Publication: US 2011/0152200
Tumor Microenvironment of Metastasis (Tmem) and Uses Thereof in Diagnosis, Prognosis and Treatment of Tumors
Patent: 8,642,277 →
Application: 12/804,779 →
Publication: US 2011/0059470
Methods for Determining Chemotherapeutic Agents Targeting Alpha-Glucan Pathways and Uses Thereof
Patent: 8,455,214 →
Application: 12/925,633 →
Publication: US 2011/0124593
Saporin-L1 inhibitors and uses thereof
Patent: 8,884,000 →
Application: 12/932,051 →
Publication: US 2011/0201674
Solid State Synthesis Hydroxyl Radicals for High Throughput Structure Determination of Proteins and Nucleic Acids by Oxidative Footprinting
Patent: 9,279,814 →
Application: 13/063,833 →
Publication: US 2011/0207616
Method of Treating Lupus Nephritis
Patent: 9,730,947 →
Application: 13/239,769 →
Publication: US 2012/0020970
Methods for Determining Agents That Treat or Prevent Obesity and/or Obesity Related Diseases and Methods for Treatment Therewith
Patent: 8,632,979 →
Application: 13/298,370 →
Publication: US 2012/0128690
Method for Functional Testing of Site-Specific Dna Methylation
Patent: 8,993,242 →
Application: 13/349,745 →
Publication: US 2012/0183961
3-Hydroxypyrrolidine Inhibitors of 5'-Methylthioadenosine Phosphorylase and Nucleosidase
Patent: 9,493,465 →
Application: 13/383,772 →
Publication: US 2012/0157479
Prostaglandin Transporter Inhibitors and Uses Thereof
Patent: 8,952,150 →
Application: 13/394,857 →
Publication: US 2012/0238577
Myosin-Iia S1943 Phosphorylation as a Marker of Tumor Invasion
Patent: 8,541,181 →
Application: 13/419,805 →
Publication: US 2012/0237952
Cell Extract Promoted Cloning
Patent: 8,609,374 →
Application: 13/526,930 →
Publication: US 2013/0045508
Fidgetin-Like 2 as a Target to Enhance Wound Healing
Patent: 8,853,181 →
Application: 13/553,155 →
Publication: US 2013/0022667
Prostaglandin Transporter Inhibitors
Patent: 9,144,573 →
Application: 13/555,408 →
Publication: US 2013/0171171
Methods of Preparing Targeted Aptamer Prodrugs
Patent: 9,540,412 →
Application: 13/643,408 →
Publication: US 2013/0123478
SIR2 Regulation
Patent: 8,835,467 →
Application: 13/747,543 →
Publication: US 2013/0231351
Methods for Quantitative Assessment of Volumetric Image from a Subject and Uses Therof
Patent: 9,245,334 →
Application: 13/775,312 →
Publication: US 2013/0223714
Method of Enhancing Efficacy of Blood Transfusions
Patent: 8,859,499 →
Application: 13/794,978 →
Publication: US 2013/0261061
Modified Glycolipids and Methods of Making and Using the Same
Patent: 9,371,352 →
Application: 13/803,972 →
Publication: US 2014/0227296
Ligands and Methods for Labeling Biomolecules in Vivo
Patent: 9,809,560 →
Application: 13/813,163 →
Publication: US 2013/0295019
Administration of SNS Neuroprotective Agents to Promote Hematopoietic Regeneration
Application: 13/823,578 →
Publication: US 2013/0230580
Biological Markers for Longevity and Diseases and Uses Thereof
Patent: 8,703,496 →
Application: 13/832,832 →
Publication: US 2013/0244333
Method for Inhibiting Metastasis by Using Anti-CCL3 Antibodies
Patent: 8,716,235 →
Application: 13/860,109 →
Publication: US 2013/0280254
Methods, Assays and Compounds for Treating Bacterial Infections by Inhibiting Methylthioinosine Phosphorylase
Patent: 9,290,501 →
Application: 13/884,298 →
Publication: US 2013/0274220
Constructs and Methods to Identify Antibodies That Target Glycans
Patent: 9,360,483 →
Application: 13/885,203 →
Publication: US 2013/0281317
HUMAN BetaV-TUBULIN ANTIBODY AND METHODS OF USE
Patent: 9,234,899 →
Application: 13/912,266 →
Publication: US 2013/0338091
Methods and Assays for Treating Filoviridae Infections
Patent: 9,234,885 →
Application: 13/979,179 →
Publication: US 2014/0018338
Radiobacteria for Therapy of Cancer
Application: 13/985,087 →
Publication: US 2014/0147379
Alternatively Spliced Mrna Isoforms as Prognostic Indicators for Metastatic Cancer
Patent: 9,926,601 →
Application: 14/000,995 →
Publication: US 2014/0066319
Oral Administration of Melanin for Protection Against Radiation
Patent: 9,408,882 →
Application: 14/005,601 →
Publication: US 2014/0037674
Antibodies to Human B7X for Treatment of Metastatic Cancer
Patent: 9,447,186 →
Application: 14/050,512 →
Publication: US 2014/0037551
Automatic Three-Dimensional Approach Method for Rf Coil Assessment in Clinical Mri
Patent: 9,417,307 →
Application: 14/051,541 →
Publication: US 2014/0176133
Metastasis Specific Splice Variants of Mena and Uses Thereof in Diagnosis, Prognosis and Treatment of Tumors
Patent: 9,719,142 →
Application: 14/074,089 →
Publication: US 2014/0057966
Human Invasion Signature for Prognosis of Metastatic Risk
Patent: 9,970,057 →
Application: 14/115,928 →
Publication: US 2014/0314786
Stromal Cell Therapy in Treatment of Radiation Injury
Patent: 9,782,441 →
Application: 14/131,776 →
Publication: US 2015/0118206
Treatment of Myocardial Injury with Humanin Analogs
Patent: 9,034,825 →
Application: 14/186,331 →
Publication: US 2014/0179610
Erythropoietic Role of Resident Macrophages in Hematopoietic Organs
Application: 14/189,110 →
Publication: US 2014/0248281
Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndromes
Patent: 9,873,918 →
Application: 14/236,118 →
Publication: US 2015/0147271
Simultaneous Extraction of Dna and Rna from Ffpe Tissues
Patent: 9,309,559 →
Application: 14/249,631 →
Publication: US 2014/0308670
Therapy for Filovirus Infection
Patent: 9,346,875 →
Application: 14/291,608 →
Publication: US 2014/0356354
Recombinant Mycobacteriophages for Delivery of Nucleic Acids of Interest into Mycobacteria
Patent: 9,447,449 →
Application: 14/352,761 →
Publication: US 2014/0370495
Neural Stem Cell Therapy for Obesity and Diabetes
Application: 14/375,582 →
Publication: US 2014/0363407
Novel Cellular Targets for Hiv Infection
Patent: 9,540,646 →
Application: 14/381,727 →
Publication: US 2015/0057331
Method of Enhancing the Efficacy of Anti-Hepatocyte Growth Factor Receptor Breast Cancer Therapy by Administering an Inhibitor of Menainv
Application: 14/390,113 →
Publication: US 2015/0044234
Transferrin Receptor Aptamers and Aptamer-Targeted Delivery
Patent: 9,439,973 →
Application: 14/396,102 →
Publication: US 2015/0125516
Nanoparticle Delivery Vehicle for S-Nitroso-N-Acetyl Cysteine and Uses Thereof
Application: 14/399,335 →
Publication: US 2015/0147396
MYCOBACTERIUM TUBERCULOSIS DeltaESX-3 MUTANTS
Patent: 9,637,749 →
Application: 14/399,557 →
Publication: US 2015/0140038
Aptamer-Targetted Antigen Delivery
Patent: 9,688,991 →
Application: 14/413,727 →
Publication: US 2015/0191730
Method to Treat or Prevent Herpesvirus Infections
Patent: 9,333,219 →
Application: 14/415,333 →
Publication: US 2015/0190419
Wnt Modulators for the Protection, Mitigation and Treatment of Radiation Injury
Application: 14/419,646 →
Publication: US 2016/0074400
Treatment of Helicobacter Pylori Infections
Application: 14/419,669 →
Publication: US 2015/0210701
Treatment and Prevention of P. Aeruginosa Infections Using Coformycin Analogs
Patent: 9,522,159 →
Application: 14/426,775 →
Publication: US 2015/0231165
Serologic Test for the Rapid Diagnosis of Active Tuberculosis
Patent: 9,841,424 →
Application: 14/434,415 →
Publication: US 2015/0260714
Regeneration of Coronary Artery by Coronary Endothelial Specific Progenitor Cells
Patent: 9,511,097 →
Application: 14/443,075 →
Publication: US 2015/0290250
Method of Enhancing Efficacy of Blood Transfusions
Patent: 9,498,537 →
Application: 14/454,059 →
Publication: US 2015/0017146
Fidgetin-Like 2 as a Target to Enhance Wound Healing
Patent: 9,279,124 →
Application: 14/487,221 →
Publication: US 2015/0105447
Retinoic Acid Receptor Antagonists as Chaperone-Mediated Autophagy Modulators and Uses Thereof
Patent: 9,512,092 →
Application: 14/566,762 →
Publication: US 2015/0166492
Methods for High Throughput Receptor:Ligand Identification
Application: 14/649,176 →
Publication: US 2016/0011204
Therapy for Radiation-Induced Lung Injury
Patent: 9,439,947 →
Application: 14/666,746 →
Publication: US 2015/0306177
Gut Barrier Dysfunction Treatment and Prevention
Patent: 9,925,222 →
Application: 14/729,211 →
Publication: US 2015/0258151
Assay for Inhibitors of Equilibrative or Concentrative Nucleoside Transporters
Application: 14/759,973 →
Publication: US 2016/0010134
A Selective High-Affinity Immune Stimulatory Reagent and Uses Thereof
Application: 14/765,885 →
Publication: US 2015/0368316
HHLA2 as a Novel Inhibitor of Human Immune System and Uses Thereof
Application: 14/770,120 →
Publication: US 2016/0002337
Treatment of Aging Effects by Gonadotropin-Releasing Hormone, Neurogenesis or Brain Ikk Beta/Nf-Kappab Inhibition
Application: 14/787,278 →
Publication: US 2016/0074467
Tuberculosis Biomarkers and Uses Thereof
Patent: 9,857,378 →
Application: 14/835,939 →
Publication: US 2016/0154005
Il-34 Receptor Assays and Uses Thereof
Patent: 9,671,391 →
Application: 14/891,405 →
Publication: US 2016/0123962
Treatment of Obesity and Pulmonary Arterial Hypertension
Patent: 9,603,852 →
Application: 14/898,576 →
Publication: US 2016/0113933
Pyrite Shrink-Film Laminate as a Hydroxyl Radical Generator
Patent: 9,880,173 →
Application: 14/980,408 →
Publication: US 2016/0187346
Recombinant Herpes Simplex Virus 2 (Hsv-2) Vaccine Vectors
Patent: 9,999,665 →
Application: 15/015,322 →
Publication: US 2016/0158343
Modified Paramagnetic Nanoparticles for Targeted Delivery of Therapeutics and Methods Thereof
Application: 15/021,333 →
Publication: US 2016/0346389
Methods and Compositions to Inhibit Metastasis and to Treat Fibrosis and to Enhance Wound Healing
Patent: 9,994,845 →
Application: 15/023,869 →
Publication: US 2016/0237428
Wnt/BETA-CATENIN INHIBITOR-ELUTING ENDOVASCULAR STENT
Application: 15/028,449 →
Publication: US 2016/0263289
Nucleic Acid-Scaffolded Small Molecule Libraries
Application: 15/032,672 →
Publication: US 2016/0266133
Fidgetin-Like 2 as a Target to Enhance Would Healing
Patent: 9,914,926 →
Application: 15/057,480 →
Publication: US 2016/0177315
Piston Device for Magnetic Resonance Elastography and Uses Thereof
Application: 15/086,163 →
Publication: US 2016/0287130
B7X and Its Derivatives for Treating and Preventing Cardiovascular Disease
Application: 15/100,995 →
Publication: US 2016/0304581
Method of Rapid Isolation of Aptamer Beacons
Application: 15/101,987 →
Publication: US 2016/0304857
Cellular Platform for Rapid and Comprehensive T-Cell Immunomonitoring
Application: 15/110,384 →
Publication: US 2017/0176435
Epigenetic Stem Cell Commitment-Associated Signature
Application: 15/111,869 →
Publication: US 2016/0340737
Treatment of H. Pylori Infections Using Mtan Inhibitors
Application: 15/118,113 →
Publication: US 2017/0166571
Methods and Assays for Treating Hantavirus Infections
Application: 15/118,504 →
Publication: US 2017/0173141
Fusion Tags for Protein Expression
Patent: 9,920,102 →
Application: 15/152,908 →
Publication: US 2016/0333061
Therapy for Filovirus Infection
Application: 15/161,634 →
Publication: US 2017/0088606
Modified Glycolipids and Methods of Making and Using the Same
Application: 15/173,226 →
Publication: US 2016/0346384
Oral Administration of Melanin for Protection Against Radiation
Application: 15/230,617 →
Publication: US 2017/0128416
Antibodies to Human B7X for Treatment of Metastatic Cancer
Application: 15/252,267 →
Publication: US 2017/0029525
Method of Diagnosis and Treatment of Tumors Using High Intensity Focused Ultrasound
Patent: 9,907,982 →
Application: 15/279,514 →
Publication: US 2017/0014651
Retinoic Acid Receptor Antagonists as Chaperone-Mediated Authophagy Modulators and Uses Thereof
Patent: 9,890,143 →
Application: 15/298,280 →
Publication: US 2017/0037039
TMIGD2 and Its Derivatives as Blockers or Binders of Cancer-Expressed HHLA2 for Immunotherapies
Application: 15/300,294 →
Publication: US 2017/0174742
Syntac Polypeptides and Uses Thereof
Application: 15/306,678 →
Publication: US 2017/0058015
Treatment of Multiple Sclerosis by Inhibition of Allograft Inflammatory Factor-1
Application: 15/308,105 →
Publication: US 2017/0073677
Targeting Dimerization of Bax to Modulate Bax Activity
Application: 15/311,861 →
Publication: US 2017/0114100
Use of Tgf-Beta Antagonists of Treat Type-2 Diabetes
Application: 15/318,022 →
Publication: US 2017/0114128
Therapy for Filovirus Infection
Application: 15/327,857 →
Publication: US 2017/0204166
3-Hydroxypyrrolidine Inhibitors of 5'-Methylthioadenosine Phosphorylase and Nucleosidase
Patent: 9,957,272 →
Application: 15/347,944 →
Publication: US 2017/0166573
Methods and Compositions for Detecting and Modulating Cancer Cells
Application: 15/351,409 →
Publication: US 2017/0168056
Multi-Specific Antibodies for Cross-Neutralization of Multiple Filovirus Glycoproteins
Application: 15/404,662 →
Publication: US 2017/0182163
Recombinant Herpes Simplex Virus 2 (Hsv-2) Vaccine Vectors
Application: 15/455,495 →
Publication: US 2017/0202952
Monomeric Near-Infrared Fluorescent Proteins Engineered from Bacterial Phytochromes and Methods for Making Same
Application: 15/497,667 →
Publication: US 2018/0044383
Methods and Compositions for Assessing Germline Risk of Cancer
Application: 15/504,726 →
Publication: US 2017/0299600
Programmed Cargo Release Using Nucleic Acid-Stabilized Micelles
Application: 15/510,285 →
Publication: US 2017/0304200
Methods to Accelerate Antibody Diversification
Application: 15/514,052 →
Publication: US 2018/0179516
Host and Intestinal Microbiota Derived Metabolomic Blood Plasma Signature for Prior Radiation Injury
Application: 15/518,284 →
Publication: US 2017/0299573
Methods and Compositions for Treating and Preventing Arthritis
Application: 15/520,156 →
Publication: US 2018/0333368
Modified Paramagnetic Nanoparticles for Targeted Delivery of Therapeutics and Methods Thereof
Application: 15/522,947 →
Publication: US 2017/0332910
Method for Producing Radiobacteria for Therapy of Cancer
Application: 15/523,790 →
Publication: US 2017/0333578
Peptides for Blocking IL1RAP Protein-Protein Interaction and Uses Thereof for Treatment of Disease
Application: 15/524,363 →
Publication: US 2018/0275123
BTNL9 and Ermap as Novel Inhibitors of the Immune System for Immunotherapies
Application: 15/525,092 →
Publication: US 2018/0296636
Treatment of Cancer Using Recall Antigens Delivered by Attenuated Bacteria
Application: 15/568,491 →
Publication: US 2018/0104320
Bispecific Antibodies and Fusion Proteins That Bind to Ebov and NPC1
Application: 15/571,512 →
Publication: US 2018/0141999
Tmem Active Test and Uses Thereof in Diagnosis, Prognosis and Treatment of Tumors
Application: 15/573,498 →
Publication: US 2018/0106811
Intervention for Tendinopathy
Application: 15/577,470 →
Publication: US 2018/0148686
Fgf Receptor Ligands for Treating Diabetes and Obesity
Application: 15/579,988 →
Publication: US 2018/0169181
Metastasis Specific Splice Variants of Mena and Uses Thereof in Diagnosis, Prognosis and Treatment of Tumors
Application: 15/661,021 →
Publication: US 2017/0335406
Methods and Compositions to Inhibit Metastasis and to Treat Fibrosis and to Enhance Wound Healing
Application: 15/706,849 →
Publication: US 2018/0057816
Therapeutic Nanoparticles and Methods Thereof
Application: 15/725,313 →
Publication: US 2018/0055877
Synthetic Antibodies to Bax and Uses Thereof
Application: 15/756,997 →
Publication: US 2018/0251532
Optogenetic System Based on Bacterial Phytochrome Controllable with Near Infra-Red Light
Application: 15/761,598 →
Publication: US 2018/0346523
Methods and Devices for Intraoperative Viewing of Patient 3D Surface Images
Application: 15/761,832 →
Publication: US 2018/0261009
Microbial Hyperswarmers and Uses Thereof
Application: 15/765,513 →
Publication: US 2018/0289753
Method of Ameliorating Side Effects of Sickle Cell Disease Treatments
Application: 15/774,763 →
Publication: US 2018/0369281
Neural Stem Cell Therapy for Obesity and Diabetes
Application: 15/783,100 →
Publication: US 2018/0105863
Methods and Compositions for Rapid Functional Analysis of Gene Variants
Application: 15/819,221 →
Publication: US 2018/0074049
Dna Methyltransferase 1 Transition State Structure and Uses Thereof
Application: 15/895,057 →
Publication: US 2018/0239878
Generation of Hepatocytes from Pluripotent Stem Cells
Application: 15/900,834 →
Publication: US 2018/0208892
Gut Barrier Dysfunction Treatment and Prevention
Application: 15/901,919 →
Publication: US 2018/0185422
Fidgetin-Like 2 as a Target to Enhance Wound Healing
Application: 15/917,968 →
Publication: US 2018/0201935
Tumor Necrosis Factor 1B (Tnf-1B) Mutants and Methods of Use Thereof to Screen for Candidate Therapeutic Compounds
Application: 15/945,887 →
Publication: US 2018/0273604
Use of 13C and 15N Derivatization Reagents for Gas and Liquid Chromatography-Mass Spectroscopy Chemical Identification and Quantification
Application: 15/967,616 →
Publication: US 2018/0275138
Recombinant Herpes Simplex Virus 2 (Hsv-2) Vaccine Vectors
Application: 15/995,471 →
Publication: US 2019/0111127
Syntac Polypeptides and Uses Thereof
Application: 16/001,153 →
Publication: US 2018/0282392
Identification and Use of New Tumor-Promoting Gene in Hematological Malignancies
Application: 16/040,877 →
Publication: US 2018/0371105
Phosphocofilin: Cofilin Co-Localization Intensity as a Predictor of Metastatic Recurrence
Application: 16/043,525 →
Publication: US 2019/0011448
Methods for High Throughput Receptor:Ligand Identification
Application: 16/044,608 →
Publication: US 2020/0011875
Nuclear Receptor Set Domain Containing Protein 2 Transition State and Uses Thereof
Application: 16/060,470 →
Publication: US 2019/0026440
Chemoenzymatic Synthesis of S-Nucleosyl Amino Acids (Sna), Analogs of S-Adenosyl-L-Methionine and S-Adenosyl-L- Homocysteine and Uses Thereof
Application: 16/063,731 →
Publication: US 2020/0239921
Dengue Virus Glycoprotein E Diii Variants and Uses Thereof
Application: 16/064,505 →
Publication: US 2018/0360946
Residue-Based Pharmacophore Method for Identifying Cognate Protein Ligands
Application: 16/068,938 →
Publication: US 2019/0369097
PAK1 Inhibitors and Uses Thereof
Application: 16/095,709 →
Publication: US 2020/0323855
Engineered Pd-1 Variants
Application: 16/096,369 →
Publication: US 2019/0127439
Variant Pd-L1 Polypeptides, T-Cell Modulatory Multimeric Polypeptides, and Methods of Use Thereof
Application: 16/098,983 →
Publication: US 2019/0153065
HHLA2 as a Novel Inhibitor of Human Immune System and Uses Thereof
Application: 16/121,771 →
Publication: US 2019/0010234
Methods Involving Menainv in Screening for Inhibitors of Cancer Invasion and Metastasis
Application: 16/130,616 →
Publication: US 2019/0137501
Filovirus Antibody
Application: 16/134,041 →
Publication: US 2019/0185547
Treatment of H. Pylori Infections Using Mtan Inhibitors
Application: 16/136,314 →
Publication: US 2019/0016730
Methods and Compositions to Inhibit Metastasis and to Treat Fibrosis and to Enhance Wound Healing
Application: 16/143,651 →
Publication: US 2019/0017049
Methods for Treating Cancer by Targeting VCAM1 and Maea
Application: 16/199,555 →
Publication: US 2019/0077878
Pu.1 Inhibitors
Application: 16/227,739 →
Publication: US 2019/0112276
Passive Transfer of Immunity Using Recombinant Herpes Simplex Virus 2 (Hsv-2) Vaccine Vectors
Application: 16/238,933 →
Publication: US 2019/0240321
Synthetic Antibodies to Bax and Uses Thereof
Application: 62/216,400 →
Optogenetic System Based on a Bacterial Phytochrome Controllable with Near Infra-Red Light
Application: 62/235,828 →
Microbial Hyperswarmers and Uses Thereof
Application: 62/237,657 →
Therapeutic Tnfr-1B Targets and Uses Thereof
Application: 62/243,688 →
Use of 13C Derivatization Reagents for Gas Chromatography-Mass Spectroscopy Chemical Identification and Quantification
Application: 62/249,981 →
Method of Ameliorating Side Effects of Sickle Cell Disease Treatments
Application: 62/252,622 →
Nuclear Receptor Set Domain Containing Protein 2 Transition State and Uses Thereof
Application: 62/268,677 →
Chemoenzymatic Synthesis of S-Nuneosyl Amino Acids (Sna), Analogs of S-Adenosyl-L-Methionine and S-Adenosyl-L-Homocysteine and Uses Thereof
Application: 62/290,502 →
Residue-Based Pharmacophore Method for Identifying Cognate Protein Ligands
Application: 62/293,026 →
Dengue Virus Glycoprotein E Diii Variants and Uses Thereof
Application: 62/295,634 →
PAK1 Inhibitors and Uses Thereof
Application: 62/332,508 →
Assays and Compounds for Treatment of Melanoma
Application: 62/336,812 →
Engineered Pd-1 Variants
Application: 62/337,388 →
Variant Pd-L1 Polypeptides, T-Cell Modulatory Multimeric Polypeptides, and Methods of Use Thereof
Application: 62/338,128 →
Methods for Treating Hematological Malignancies
Application: 62/342,360 →
Pu.1 Inhibitors
Application: 62/353,669 →
Chemically Modified Rna Aptamers and Uses Thereof
Application: 62/408,859 →
Drug Targeting of Human Indoleamine 2, 3-Dioxygenase
Application: 62/430,408 →
Pxr Agonists and Uses Thereof for Gut Barrier Dysfunction Treatment and Prevention
Application: 62/447,716 →
Co-Localization at Molecular Resolution of Multiple Fluorescence Channels Acquired Using Optical Microscopy
Application: 62/451,096 →
Dna Methyltransferase 1 Transition State Structure and Uses Thereof
Application: 62/461,268 →
Characterization of S-Adenosyl-L-Methionine-Consuming Enzymes with 1-Step Ez-Mtase: a Universal Coupled-Assay
Application: 62/462,429 →
Small Molecule Bax Inhibitors and Uses Thereof
Application: 62/469,551 →
Precision Activation of Hiv-Specific Ctls to Eliminate Reactivated Latent T Cells
Application: 62/482,235 →
RNA TAGGING SYSTEM FOR VISUALIZATION OF SINGLE mRNA MOLECULES
Application: 62/487,058 →
Non-Invasive Optogenetic Stimulation Method to Regulate Glucose Metabolism in the Liver and Brown Adipose Tissue
Application: 62/487,599 →
Method for Treating Neoadjuvant Chemotherapy-Induced Metastasis
Application: 62/512,298 →
Bax Activators and Uses Thereof in Cancer Therapy
Application: 62/513,488 →
Methods for Expanding Hematopoietic Stem Cells Using Revitalized Mesenchymal Cells
Application: 62/517,271 →
Method for Treating Neoadjuvant Chemotherapy-Induced Metastasis
Application: 62/524,690 →
Bax Activators and Uses Thereof in Cancer Therapy
Application: 62/546,041 →
Broad Spectrum Viral Inhibitor
Application: 62/548,425 →
High Resolution Intravital Imaging and Uses Thereof
Application: 62/548,455 →
Mitofusin Activators and Uses Thereof
Application: 62/573,217 →
Prevention and Treatment of Viral Infections
Application: 62/592,583 →
Immunregulatory Role of 3-Oh-L-Kynurenamine and Uses Thereof
Application: 62/642,633 →
High-Affinity Mycobacterium Tuberculosis Capsule-Specific Human Monoclonal Antibody
Application: 62/657,253 →
HSV-2-DELTA-gD VACCINES AND METHODS FOR THEIR PRODUCTION AND USE
Application: 62/665,050 →
Antibodies Targeting Chikungunya Virus Glycoprotein
Application: 62/681,247 →
Tmem-Mcd in the Minimally Invasive Assessment of the Activity Status of Tmem in Its Dissemination of Tumor Cells
Application: 62/683,692 →
Monoclonal Antibodies Against Human Tim-3
Application: 62/720,234 →
Interleukin-8 for Maintenance of Human Acute Myeloid Leukemia and Myelodysplastic Syndrome and Uses Thereof
Application: 62/735,213 →
Mutant Variants of Pd-1 Receptor with Selective Binding to Pd-L1 and Uses Thereof
Application: 62/736,477 →
High-Affinity Mycobacterium Tuberculosis Capsule-Specific Human Monoclonal Antibody
Application: 62/739,428 →
Method of Enhancing Antibody-Dependent Cell-Mediated Cytotoxicity (Adcc)
Application: 62/746,731 →
siRNA-ENHANCED POLOXAMER-BASED HYDROGEL WOUND HEALING
Application: 62/749,325 →
Double Auxotrophic Mycobacterium and Uses Thereof
Application: 62/764,696 →
MONOCLONAL ANTIBODIES AGAINST IgV DOMAIN OF B7-H3 AND USES THEREOF
Application: 62/768,128 →
ANTAGONIST MONOCLONAL ANTIBODIES AGAINST HUMAN IMMUNE CHECKPOINT CEACAM1 (CD66a)
Application: 62/782,785 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 16, 2015
From: SEIDEL III, RONALD D.; CHAPARRO, RODOLFO; HILLERICH, BRANDAN S.; ALMO, STEVEN C.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Reel/Frame 035170/0934 →
Assignment of Assignor's Interest Mar 16, 2015
From: SCHRAMM, VERN L.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Reel/Frame 035171/0475 →
Assignment of Assignor's Interest Mar 25, 2015
From: WU, PENG; ROUHANIFARD, SARA; ZHENG, TIANQING
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Reel/Frame 035251/0538 →
Assignment of Assignor's Interest Mar 26, 2015
From: CHANDRAN, KARTIK; JANGRA, ROHIT K.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERISTY
Reel/Frame 035264/0324 →
Assignment of Assignor's Interest Apr 6, 2015
From: HEROLD, BETSY
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Reel/Frame 035337/0716 →
Assignment of Assignor's Interest Apr 7, 2015
From: JACOBS, JR., WILLIAM
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 035349/0242 →
Assignment of Assignor's Interest Apr 29, 2015
From: GONZALEZ MUNOZ, PABLO A.
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 035524/0381 →
Assignment of Assignor's Interest May 19, 2015
From: SIBINGA, NICHOLAS ERNST SMIT; CHINNASAMY, PRAMELADEVI; LUTZ, SARAH E.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Reel/Frame 035669/0185 →
Assignment of Assignor's Interest Jun 8, 2015
From: FRIEDMAN, JOEL M.; NAVATI, MAHANTESH S.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Reel/Frame 035802/0505 →
Assignment of Assignor's Interest Aug 11, 2015
From: GAVATHIOTIS, EVRIPIDIS
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Reel/Frame 036296/0917 →
Assignment of Assignor's Interest Aug 31, 2015
From: CAI, DONGSHENG
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Reel/Frame 036455/0760 →
Assignment of Assignor's Interest Sep 22, 2015
From: DYE, JOHN M; ZAK, SAMANTHA
To: THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY
Reel/Frame 036622/0043 →
Assignment of Assignor's Interest Oct 13, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036851/0385 →
Assignment of Assignor's Interest Oct 15, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036875/0057 →
Assignment of Assignor's Interest Oct 16, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036876/0363 →
Assignment of Assignor's Interest Oct 16, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036876/0301 →
Assignment of Assignor's Interest Oct 16, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036877/0885 →
Change of Name Oct 19, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036888/0927 →
Change of Name Oct 19, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036887/0324 →
Change of Name Oct 20, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036900/0216 →
Change of Name Oct 20, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036900/0158 →
Change of Name Oct 20, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036907/0536 →
Assignment of Assignor's Interest Oct 26, 2015
From: LAI, JONATHAN R.; KOELLHOFFER, JAYNE F.; FREI, JULIA; CHANDRAN, KARTIK
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036879/0914 →
Assignment of Assignor's Interest Nov 3, 2015
From: HOWARD HUGHES MEDICAL INSTITUTE
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036946/0039 →
Assignment of Assignor's Interest Nov 16, 2015
From: LEVY, MATTHEW; WILNER, SAMANTHA E.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 037049/0272 →